Video: FDA Approves Breakthrough Migraine Medication

 




 

 FDA Approves Breakthrough Migraine Medication

 

 

FRI, MAY 2018 

 

 

The first medicine designed to prevent migraines was approved by the Food and Drug Administration on Thursday, ushering in what many experts believe will be a new era in treatment for people who suffer the most severe form of these headaches.

 

 

Aimovig works by blocking the molecule CGRP, which in high levels can cause the body to feel more pain — migraine sufferers often have high levels of it..

 

 

976
-